<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Daniel Carpenter</style></author><author><style face="normal" font="default" size="100%">Susan Moffitt</style></author><author><style face="normal" font="default" size="100%">Colin Moore</style></author><author><style face="normal" font="default" size="100%">Ryan Rynbrandt</style></author><author><style face="normal" font="default" size="100%">Michael Ting</style></author><author><style face="normal" font="default" size="100%">Ian Yohai</style></author><author><style face="normal" font="default" size="100%">Evan James Zucker</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">“Early-Entrant Protection in Approval Regulation: Theory and Evidence from FDA Drug Review”</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Law  Economics and Organization  </style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year></dates><volume><style face="normal" font="default" size="100%">26</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">2</style></issue><notes><style face="normal" font="default" size="100%">e-published April 2009 at doi: 10.1093/jleo/ewp002</style></notes></record></records></xml>